Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P01732: Variant p.Gly111Ser

T-cell surface glycoprotein CD8 alpha chain
Gene: CD8A
Feedback?
Variant information Variant position: help 111 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Glycine (G) to Serine (S) at position 111 (G111S, p.Gly111Ser). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to small size and polar (S) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In IMD116; prevents CD8 expression. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 111 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 235 The length of the canonical sequence.
Location on the sequence: help GKRLGDTFVLTLSDFRRENE G YYFCSALSNSIMYFSHFVPV The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         GKRLGDT-FVLTLSDFRRENEGYYFCSALSNSIMYFSHFVPV

                              GQKKTDSTYSLTLSRFRKEDEGYYFCSVLSNSILYFSPFVP

Mouse                         AMRDTNNKYVLTLNKFSKENEGYYFCSVISNSVMYFSSVVP

Rat                           A-RKENNKYILTLSKFSTKNQGYYFCSITSNSVMYFSPLVP

Bovine                        GAKVSGTKFQLTLSSFLQEDQGYYFCSVVSNSILYFSNFVP

Cat                           GQRIQDTLYSLTLHRFRKEEEGYYFCSVVSNSVLYFSAFVP
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 22 – 235 T-cell surface glycoprotein CD8 alpha chain
Topological domain 22 – 182 Extracellular
Domain 22 – 135 Ig-like V-type
Disulfide bond 43 – 115
Mutagenesis 111 – 111 G -> R. Prevents CD8 expression.
Beta strand 111 – 119



Literature citations
Familial CD8 deficiency due to a mutation in the CD8 alpha gene.
de la Calle-Martin O.; Hernandez M.; Ordi J.; Casamitjana N.; Arostegui J.I.; Caragol I.; Ferrando M.; Labrador M.; Rodriguez-Sanchez J.L.; Espanol T.;
J. Clin. Invest. 108:117-123(2001)
Cited for: VARIANT IMD116 SER-111; MUTAGENESIS OF GLY-111; Gly111Ser mutation in CD8A gene causing CD8 immunodeficiency is found in Spanish Gypsies.
Mancebo E.; Moreno-Pelayo M.A.; Mencia A.; de la Calle-Martin O.; Allende L.M.; Sivadorai P.; Kalaydjieva L.; Bertranpetit J.; Coto E.; Calleja-Antolin S.; Ruiz-Contreras J.; Paz-Artal E.;
Mol. Immunol. 45:479-484(2008)
Cited for: VARIANT IMD116 SER-111;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.